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ABSTRACT
Cancer cells can be described as an invasive species that is able to establish itself in a new environment. The concept of niche construction can
be utilized to describe the process by which cancer cells terraform their environment, thereby engineering an ecosystem that promotes the
genetic ﬁtness of the species. Ecological dispersion theory can then be utilized to describe and model the steps and barriers involved in a
successful diaspora as the cancer cells leave the original host organ and migrate to new host organs to successfully establish a new metastatic
community. These ecological concepts can be further utilized to deﬁne new diagnostic and therapeutic areas for lethal cancers. J. Cell.
Biochem. 115: 1478–1485, 2014. © 2014 The Authors. The Journal of Cellular Biochemistry Published by Wiley Periodicals, Inc. This is an open access article
under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in anymedium, provided the original work is
properly cited, the use is non–commercial and no modiﬁcations or adaptations are made.
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The cooperative construction of a new tumor niche throughecological engineering is a keystone event for the formation and
function of a cancerous lesion. The evolving niche changes the ordered
organ microenvironment into a disordered malignant microenviron-
ment that in turn changes the genotypes and phenotypes of both cancer
and host cells. This new heterogeneous environment is built in a
cooperative manner between cancer and host cells, induces a high rate
of tumor cell heterogeneity. Natural selection and therapeutic selection
ensueand selected cancer cells survive to continue theprocess locally or
through a diaspora to a distant site.
CANCER AND NICHE CONSTRUCTION
A niche in ecology refers to both the place a species lives as well as
the role it plays in its habitat, including the dynamic ﬂow of
information and energy around it (Grinnell, 1917; Hutchinson,
1957; Elton, 2001). It includes how an individual organism, or the
population of its species in that ecosystem, utilizes and responds
to resources, the abiotic environment it interacts with, and the
stresses caused by competitors and environmental changes. The
sciences of ecology, evolution, population biology, and sociology
have created many paradigms that can be utilized to better
understand cancer and the processes of tumorigenesis and
metastasis (Chen and Pienta, 2011; Camacho and Pienta, 2012;
Pienta et al., 2013; Akiptis et al., 2013; Scott et al., 2013, 2014). Niche
construction theory integrates ecosystem ecology theory and
evolutionary dynamics to explain the interplay between a species,
its environment and genetic drift (Odling-Smee et al., 2003, 2013;
Erwin, 2008; Kylaﬁs and Loreau, 2008; Krakauer et al., 2009; Post
and Palkovacs, 2009; Loreau, 2010; Van Dyken and Wade, 2012).
Niche construction is the process whereby organisms, through their
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metabolic activities and other behaviors, modify their own and/or
each other’s niches (Odling-Smee et al., 2003, 2013). As a
consequence of these behaviors, niche construction may result in
changes in one or more natural selection pressures in the external
environment of their own or others populations. Species that
construct niches may also be referred to as ecosystem engineers
(Jones et al., 1994, 1997; Badano and Cavieres, 2006).
CANCER CELLS AS ECOLOGICAL ENGINEERS
Ecosystem engineers construct and modify their niche (Jones
et al., 1994, 1997; Badano and Cavieres, 2006). Allogenic engineers
modify their environment by mechanically changing their environ-
ment (e.g., beavers). Autogenic engineers modify their environment
by changing themselves over time (e.g., trees as they grow) (Jones
et al., 1994, 1997; Badano and Cavieres, 2006). Many invasive
species function as ecosystem engineers as they change the
ecosystem around them as they construct a niche that is favorable
to their own survival (Hickman et al., 2010; Chen and Pienta, 2011).
Cancer cells function as both allogenic and autogenic engineers
(Fig. 1). As allogenic engineers, for example, they secrete matrix
metalloproteinases that physically alter their environment (Hanahan
and Weinberg, 2011). The secretion of vascular endothelial growth
factor (VEGF) attracts the formation of new vasculature to the
local tumor ecosystem (Wey et al., 2004; Hanahan and Weinberg,
2011; Catalano et al., 2013; Burkholder et al., 2014). As autogenic
engineers, tumors grow in size, changing the architecture, pH, and
interstitial pressure of the organ host ecosystem in which they live
(Jain, 2012; Barar and Omidi, 2013; Stylianopoulos and Jain, 2013).
This fundamentally changes the growth patterns of host cell species
as well as changes the ﬂow of nutrients and information in the forms
of cytokines, chemokines, hormones and exosomes as they trafﬁc
through the ecosystem (Jain, 2012; Barar and Omidi, 2013;
Stylianopoulos and Jain, 2013).
Niche construction by an invasive species fundamentally changes
the ecosystem in which it establishes. Initially, cancer cells, even
when they arise in a primary organ site, act as an invasive species.
Odling-Smee theorized that niche construction can cause ecological
inheritance (Odling-Smee et al., 2003, 2013). Ecological inheritance
is the inheritance, via an external environment, of one or more
natural selection pressures previously modiﬁed by niche-construct-
ing organisms (Odling-Smee et al., 2003, 2013). The concept of
ecological inheritance depends on a species leaving the altered niche
to their offspring, i.e., the next generation of the species is born into
the engineered environment. This engineered environment can then
speed the process of the selection of genetic factors that increases a
species’ chances of survival. Tumor cell heterogeneity is a well-
known concept in cancer biology and is generally attributed to
intrinsic genetic instability (Pienta et al., 1989; Hunter, 2006;
Hanahan and Weinberg, 2011; Klein, 2013). The concept of
ecological inheritance suggests that the production of tumor cell
heterogeneity may be increased through niche construction/
ecological engineering (Fig. 1). Given these ﬁndings, it is possible
that this is a plausible concept (Fig. 2). For example, does the fact that
cancer cells create a hypoxic, nutrient—low environment lead to
increased clonal heterogeneity or less as only a few adaptive clones
survive? In the case of cancer, ecological inheritance of the
malignant niche appears to promote the biodiversity of the cancer
species (tumor cell heterogeneity), ultimately resulting in the
development, selection, and survival of lethal clones.
A fundamental difference between ecological engineers in nature
and cancer cells appears to be the health and longevity of the niche
Fig. 1. Cancer cells as ecological engineers. Ecosystem engineers construct and modify their niche to create environmental conditions that favor their survival. Cancer cells, for
example, function as engineers as they secrete matrix metalloproteinases that physically alter their environment, attract the formation of new vasculature, change the
architecture, pH, and interstitial pressure of the organ host ecosystem in which they live. This fundamentally changes the growth patterns of host cell species as well as changes
the ﬂow of nutrients and information in the forms of cytokines, chemokines, hormones, and exosomes as they trafﬁc through the ecosystem. Tumor cell heterogeneity is
promoted through inherent genetic instability as well as the ecological inheritance through adaptive selection.
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that the species constructs. A good example of this is when a beaver
creates a pond that supports life and is passed onto its offspring. The
beaver creates a beautiful pond, not a stagnant swamp. The human
mind automatically assumes and looks for the “healthy” ecosystem.
Nothing about a cancer microenvironment looks healthy to us. As
cancer cells divide, they outstrip their blood supply, creating a
nutrient poor, poorly oxygenated, acidic stagnant swamp rather
than a healthy pond. The cancer swamp hardly seems conducive to
growth and yet, this is exactly the environment the cancer cells may
need to accelerate the generation of adaptive clones that have the
ability to metastasize. As a secondary consequence, an environment
is created that destroys the niches of normal host cells with resultant
organ destruction, that is, an ecological spillover. Even the beaver
drives out normal species (e.g., trees living in the upstream drainage)
while creating new habitats for non-beaver species (ducks, ﬁsh). In
much the same way, cancer changes the host cells present in the
organ ecosystem, destroying (e.g., epithelial cells) and attracting
others (e.g., tumor associated macrophages).
The concepts of ecological engineering and niche construction
may have diagnostic and therapeutic implications. Diagnostic tools
that detect areas of loss of tissue metabolic homeostasis could
potentially lead to earlier cancer detection. Areas of hypoxia or
low pH could signify a growing collection of tumor cells. It is
possible that metastatic cancer would occur at a much slower rate if
cells were not forced to adapt as they are subjected to the stresses of
the developing cancer stagnant swamp. Agents that block this
adaptation could be developed—a prime target of pharmacological
inhibition is HIF-1a (Semenza, 2012; Chaturyedi et al., 2013). HIF-
1amediates many of the stress response pathways that are the result
of hypoxia. The strategic trick would be to use a speciﬁc pharmacologi-
cal inhibitor of HIF-1a early in the process of niche construction at the
primary and/or metastatic sites. Similarly, targeting other stress
response proteins by repurposing inhibitors to use them early in
targeting cancer niche construction events may be fruitful.
CANCER METASTASIS AS A FORM OF ECOLOGICAL
DISPERSAL
Once a lethal cancer successfully establishes a niche in the primary
organ, it invariably metastasizes (Hanahan and Weinberg, 2011;
Klein, 2013; Scott et al., 2013; Lavi et al., 2014). We have utilized the
social science concept of diaspora to describe metastasis in terms of
the traits a species must have to successfully leave the original host
organ and migrate/disperse to new host organs, and then
successfully establish a new community (Fig. 3) (Pienta et al.,
2013). For a species to successfully disperse, it must travel to a new
area, tolerate conditions of a new habitat and reproduce (Fig. 4).
Ecologists have deﬁned types of dispersal events, including diffusion
and jump dispersal (Suarez et al., 2001 De Valpine et al., 2008)
(Table I). Diffusion is the slow dispersal of individuals spreading out
from the margins of the species’ range. This is accomplished over
generations and is dependent on multiple factors, including food
supply and successful population growth. For example, house
sparrows were introduced into North America (jump dispersal event)
when birds fromEnglandwere released in NewYork City in 1852 and
then by diffusion dispersal have spread from Central America to
Fig. 2. Modeling ecological inheritance. Niche construction by a species
fundamentally changes the ecosystem in which it establishes. The theory of
ecological inheritance describes the inheritance, via an external environment,
of one or more natural selection pressures previously modiﬁed by the ecological
engineer species. Ecological inheritance depends on a niche existing across
multiple generations of a species, that is, the next generation of the species is
born into the engineered environment. This engineered environment can then
speed the process of the selection of genetic and epigenetic factors that
increase a species’ chances of survival. Gene pool 1 reﬂects the amount of
tumor cell heterogeneity that is a result of the intrinsic genetic instability of
cancer cells. Gene pool 2 reﬂects the increased amount and rate of genetic
instability as a result of the malignant niche environment created by the
ecological engineering of the cancer cells. Ultimately, this results in increased
ﬁtness of the species as cancer cell clones are generated that have the attributes
necessary for survival and metastasis.
Fig. 3. The cancer diaspora. The diaspora paradigm takes into account and
models several variables in the metastatic cascade. A diaspora is started by
unfavorable conditions in a homeland, leading to the voluntary or forced
eviction of a population. The nutrient poor and hypoxic environment of the
evolving primary tumor microenvironment reﬂects this. The diaspora concept
also accounts for the ﬁtness of individual cancer cell migrants and migrant
populations. Since diaspora communities remain in contact with their
homeland, it also describes and models the bidirectional movement of
cancer and host cells between cancer sites (including between primary and
metastases as well as between metastases). By describing the receptivity of the
new hostland for the arriving migrants, the diaspora also models the quality of
the target microenvironments to establish metastatic sites (adapted from
Pienta et al., 2013).
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northern Canada. (Johnston et al., 1973; Healy et al., 2009). This
concept is analogous to cancer cells at a primary tumor site simply
growing in number, resulting in a larger tumor over time, which
clearly takes multiple generations of clonal growth and establish-
ment of new blood supplies to allow delivery of oxygen and
nutrients. Jump dispersal is a long-distance dispersal over
inhospitable terrain accomplished during a relatively short period.
It occurs infrequently, but results in the presence of a species in
distinct geographical locations, for example, movement of birds
between islands. Cancer cell metastasis through the blood stream is
an example of jump dispersal as tumor cells leave the primary organ
and travel to establish at distant organs (Chen and Pienta, 2011;
Hanahan and Weinberg, 2011; Semenza, 2012; Klein, 2013; Pienta
et al., 2013). Just as some species are better at jump dispersal than
others (e.g., better suited to survive transport by water or wind),
different cancer cells are better suited to survive the jump through
the blood stream (Charpentier and Martin, 2013; Lianidou
et al., 2013; Lowes and Allan, 2014; Tinhofer et al., 2014). Cells
that have undergone EMT or cancer stem cells appear to survive in
the circulation better than those with an epithelial phenotype
(Charpentier and Martin, 2013).
Barriers to migration include abiotic and biotic features that
preclude successful dispersal (Fig. 4). These barriers can also be
considered “ﬁlters” that prevent movement of a species from one
Fig. 4. Cancer metastasis as a form of ecological dispersal. Once a cancer successfully establishes a niche in the primary organ, it invariably metastasizes. Disseminated cancer
cells use the blood stream to undergo jump dispersal and if they are able to surpass dispersal and niche ﬁlters they can act as an invasive species and establish a foothold in distant
sites. Eventually they may proliferate and act as ecological engineers to form a new niche in the target organ.
TABLE I. Types of Dispersal Events in Earth Ecology and Cancer Ecology
Types of dispersal events Earth ecology Cancer ecology
Jump dispersal
Long distance dispersal accomplished during a relatively short
period of time (occurs infrequently but explains species in
different sites)
Movement of species with wind, or carried by artificial
means (movement of sparrows from England to North
America)
Movement of cancer cells
through the bloodstream.
Diffusion
Slow dispersal of individuals spreading out from the margins
of the species’ range (accomplished over generations
Movement of species as they reproduce and move to
nearby favorable environments (sparrows in North
America)
Growth of a primary tumor
or a cancer at a
metastatic site.
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place to another, or in the case of cancer, from a primary to
metastatic site or, from one primary metastatic site to a secondary
metastatic site. In ecology, dispersal barriers or ﬁlters are deﬁned as
“abiotic or biotic [factors] that restrict movement of genes or
individuals from one place to another” (Boulangeat et al., 2012).
Multiple organisms such as whales face predation barriers during
their migration to warmer waters to breed. Likewise, cancer cells face
physical and ecological barriers during their migration to distant
organs, analogous to dispersal ﬁlters, which include unfavorable
environmental conditions in the blood circulation and encounters
with the host immune system.
The tight vascular junctions of the endothelial vessels serve as one
of the early dispersal ﬁlters for potentially successful metastatic
cancer cells (Kim et al., 2009; Nguyen et al., 2009; Comen and
Norton, 2012) (Fig. 4). After successful intravasation, the turbulent
bloodstream itself serves as another early dispersal barriers of
metastasis since less than 1% of circulating tumor cells (CTCs)
survive (Fidler, 1973). Upon entry into the bloodstream, these CTCs
face a foreign and rather harsh environment where they are
susceptible to anoikis, a form of programmed cell death triggered by
detachment from the extracellular matrix (ECM) by cells that are
normally anchorage-dependent (Weiss et al., 1981; Faraji and
Eissenberg, 2013; Ramakrishna and Rostomily, 2013). Unlike red
blood cells, tumor cells are not able to withstand the shear force of
the rapid bloodﬂow (Faraji and Eissenberg, 2013). In addition, tumor
cells have a diameter that is three to four times wider than capillaries
and some appear to bemore rigid or more prone to cluster, which can
trap them in the narrow vessels and cause them to die in circulation
before reaching their preferred secondary site (Fidler, 1970; Faraji
and Eissenberg, 2013; Plaks et al., 2013).
The concept of anartiﬁcial dispersalﬁlter for diagnosis and therapy
in the formofanecological trap is an intriguingone. Ecologic traps are
poor-quality habitats that are highly attractive to wildlife species
based on environmental cues that typically signify a high-quality
habitat (Shiozawa et al., 2011; Li and Mooney, 2013; Pienta
et al., 2013; Robertson et al., 2013; Van der Sanden et al., 2013). A
prototypical example is a mosquito being attracted to a bright
light and then dying from the heat. An indwelling ﬁlter in the blood
stream, infused with a chemoattractant such as stromal derived
factor-1 (SDF-1), could catch CTCs (Shiozawa et al., 2011).
In addition, CTCs interact with different cell types, many of which
are the host immune cells that can recognize and eliminate cancer
cells (Tarhini et al., 2014) (Fig. 4). Immune cells are constantly
circulating the bloodstream and monitoring for any foreign species.
Unlike bacteria, viruses, or parasites, cancer cells are not foreign to
the host. However, because of aberrant changes in their genetic
makeup and cell biology, they may express antigens distinct from
normal host cells (Plaks et al., 2013). Expression of tumor antigens
can be recognized by circulating leukocytes such as natural killer
cells and CD8þ T cells that can recognize tumor antigens presented
by MHC molecules and trigger cytokine release to recruit macro-
phages, eosinophils andmast cells as well as trigger lysis or apoptosis
of the tumor cell (Zitvogel et al., 2008). The greater number of
immune cells in circulation compared to the number in the primary
tumor allows immune cells to effectively eliminate CTCs (Knutson
and Disis, 2005; Wan et al., 2013).
CTCs that are able to surpass these dispersal ﬁlters are able to
successfully leave their primary tumor sites to reach their target organs
where they may undergo self-renewal to establish a new colony of
disseminated tumor cells (DTCs). There is still a barrier, however
between reaching their target and successfully self-seeding there.
These sets of barriers are referred to as niche ﬁlters (Maire et al., 2012;
Thuiller et al., 2013). In ecology,nicheﬁlters “select for species that can
establish and maintain positive population growth under the given
environmental conditions” (Maire et al., 2012; Thuiller et al., 2013).
These selective pressures include speciesﬁtness, abiotic environmental
conditions, and biotic inter-species competition (Maire et al., 2012;
Thuiller et al., 2013). In order to establish a newniche in the secondary
target organ, cancer cells must overcome niche ﬁlters such as “soil”
quality, host cell occupancy, and the immune system.
In 1889, Stephen Paget highlighted the importance of the soil as
well as the organ microenvironment or niches for metastatic
colonization in his seed and soil hypothesis (Paget, 1889; Matho and
Stenninger, 2012). Many types of cancer metastases show organ-
speciﬁc dissemination, such as breast and prostate cancer to the bone
marrow (Nguyen et al., 2009). The seeding/colonization potential of
DTCs depends largely on speciﬁc molecular interactions between the
cancer cells and the host microenvironment of the metastatic site.
The soil quality is deﬁned by how receptive a particular target organ
is to DTCs. It is determined by factors in the tumormicroenvironment
that facilitate the successful survival and colonization of dissemi-
nated cancer cells DTCs. These factors include ECM components and
basement membranes, stromal cell types, chemokines, cytokines,
and hormones, reactive oxygen species (ROS), the availability of
nutrients and oxygen, and presence of immune system cells (Gupta
and Massagué, 2006; Steeg, 2006; Oskarsson et al., 2014).
ECM components are the ﬁrst physical barrier for DTC invasion of
the secondary site (Fig. 4). In order for DTCs to successfully land and
colonize distant organ sites, appropriate interactions with speciﬁc
adhesion and signaling molecules are required. These signals are
crucial for proliferative signaling cascades within the cells. For
example, breast cancer cells require binding interactions with ECM
components such as collagen I and ﬁbronectin in the lung
parenchyma via b1-containing integrins for FAK-mediated prolif-
eration in the lung (Shibue and Weinberg, 2009; Wan et al., 2013).
Cells that lack these pro-proliferative interactions undergo apoptosis
and therefore are unable to survive at the secondary organ site.
Stromal cell types also determine the viability of DTCs at target
organ sites. Both breast and prostate cancer metastasis localize to
the bone marrow. The bone marrow niche houses a large number
of stromal cells such as osteoblasts, endothelial cells, adipocytes,
mesenchymal stem cells, and CXCL12-abundant reticular cells
(Pedersen et al., 2012). Osteoblasts secrete the cytokine SDF-1 that
interacts with CXCR4 or CXCR7 receptors on prostate cancer cells
to stimulate the invasion and homing to the bone marrow.
Disrupting the SDF-1/CXCR4 pathway by either depleting SDF-1
or blocking CXCR4 or CXCR7 receptors disrupts the ability of
prostate cancer cells to colonize the hematopoeitic stem cell niche
(Pedersen et al., 2012). In addition, competitionwith stromal-derived
growth-suppressive signals such as bone morphogenic protein
(BMP) in the lung parenchyma can hinder colonization (Wan et al.,
2013).
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The action of osteoblasts also highlights the importance of soluble
factors such as chemokines, cytokines, and hormones or growth
factors in inﬂuencing the tumor microenvironment. Tumor cells can
also secrete factors such as TGFb to remodel the target organ to be
more receptive to DTC homing or to prime themselves for organ
inﬁltration (Wan et al., 2013). However, many organ microenviron-
ments are non-receptive to tumor cell signals or express signals
incompatible with tumor cell survival and therefore pose a threat to
the viability of DTC seeds (Nguyen et al., 2009).
ROS are another important factor in the quality of the secondary
tumor microenvironment. ROS including free radicals and peroxides
are natural byproducts of aerobic metabolism in normal cells. In the
absence of tight regulation, excess ROS can induce oxidative stress,
DNA damage and DNA mutations to initiate tumorigenesis (Waris
and Ahsan, 2006; Nishikawa, 2008; Sreevalsan and Safe, 2013).
However, over-accumulation of ROS can also activate apoptotic
pathways and suppress proliferative signals that threaten the
survival of cancer cells (Sreevalsan and Safe, 2013).
DTCs that survive upon encounter with the target organ require
sufﬁcient nutrients and oxygen to initiate seeding. For example,
cancer cells require angiogenesis for growth and expansion of the
tumor via the diffusion of nutrients from blood vessels. Cancer cells
that cannot activate the angiogenic “switch” upon arrival at the
target organ or that are far from capillaries are unable to form viable
colonies and undergo apoptosis or dormancy (Folkman, 1971;
Zetter, 1998). At the same time, some but perhaps not all DTCs that
arrive in a target organ are either induced to become dormant or may
initially lack the machinery for growth in a diaspora setting.
Additional genetic lesions may be required prior to the emergence of
metastatic outgrowths or may need to terraform their new
environment to establish conditions suitable for growth.
In addition to copingwith the compatibility of the soil niche, DTCs
must compete with the native host cells for available nutrients and
survival signals. The ecosystem of the tumor microenvironment is
characterized by the dynamic interactions between the organisms,
which in this case are the cancer cells and host cells. Similar to
ecological communities, these organisms compete with each other
to survive in an environment with limited resources (Pienta
et al., 2008). While the metastatic site is completely occupied with
native cell populations, only a minority of DTCs survives the
dispersal ﬁlters and barriers upon initial arrival. Therefore, based on
population size, DTCs are already at a disadvantage to the host cells
(Gatenby, 1991). Furthermore, competitive interactions between the
two cell populations can activate tumor suppressive mechanisms to
favor wild-type cells. Surrounding host cells can sense the presence
of aberrant cells and eliminate them by extrusion from the tissue
epithelium and induction of growth arrest, differentiation, engulf-
ment, and apoptosis. Other mechanisms include secretion of
cytotoxic soluble ligands such as IL-25 and secretion of tumor
suppressive microRNAs such as miR143 that inhibit tumor
proliferation (Wagstaff et al., 2013). While DTCs compete with
wild-type host cells to survive in their new niche, they are also highly
susceptible to the resident immune cells at the metastatic site.
A subset of immune cells that trafﬁc to the metastatic
microenvironment are called tumor inﬁltrating lymphocytes (TILs)
(Salerno et al., 2014). These include macrophages, dendritic cells,
natural killer cells, B cells, and effector T cells (Fridman et al., 2012).
Cytotoxic CD8þ T cells have been largely implicated in antitumor
immunity. Similar to their circulating counterparts, CD8þ T cell
inﬁltrates recognize tumor peptide antigens, present them to MHC
class I molecules and release cytokines to induce the killing of tumor
cells (Yu and Fu, 2006; Mitchell et al., 2014).
The niche ﬁlter barrier is another therapeutic target. CTCs appear
to intravasate into a target organ and then undergo a period of
dormancy before starting the process of niche construction and
naturalization that results in a clinical metastasis (Gupta and
Massagué, 2006; Steeg, 2006; Atkipis et al., 2013; Pienta et al., 2013;
Oskarsson et al., 2014; Scott et al., 2013, 2014). Mobilization of these
cells prior to their proliferation could lead to their destruction and an
interruption of the diaspora process. Shiozawa and colleagues
demonstrated the ability of AMD3100, an inhibitor to the receptor
for SDF-1, CXCR4, to mobilize prostate cancer cells out of the bone
marrow and into the circulation where they could be destroyed
(Wang et al., 2006; Shiozawa et al., 2011).
For DTCs, successful colonization of the target organ remains a
challenge because of these niche ﬁlters. Their survival in the foreign
microenvironment is determined largely by their interactions with
new cell types and cell substrates that induce multiple molecular
mechanisms to combat the presence and colonization of the mutant
cells. Yet DTCs have evolved to become highly resistant against the
host response. Metastasis still remains the cause of 90% of cancer-
related deaths (Loberg et al., 2007).
CONCLUSIONS: THE CANCER SPECIES NICHE
CONSTRUCTION PARADOX
In nature, many invasive species act as a ecological engineers to
create a niche that is conducive to its survival. From an ecological
perspective, cancer appears to not make sense because it does not
create an ecosystem that achieves equilibrium or a steady-state that
allows it to survive as a species—it does not construct a stable niche.
But it does engineer a niche that allows it to perpetuate itself and
spread (Fig. 4). Since there is no negative feedback or control, it
ultimately causes organ destruction and the death of the host and
itself. From an evolutionary standpoint then, cancer does not appear
to be successful. This all depends on perspective.
In ecological and evolutionary terms, cancer is the prototypical
“successful” invasive specieswhen looked at in terms of generation and
timescale. It lives for thousandsofgenerations andconstructs aprimary
niche that forces it to acquire added qualities that then allow it to
spread and invade new environments. Often it is only stopped by the
death of the host biosphere. All species in nature live within the earth’s
biosphere and species that survive and propagate within it are
considered successful—but thiswill only be truewhile the earth remains
healthy.
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